Literature DB >> 20711663

Hereditary breast cancer and genetic counseling in young women.

Joan Brunet1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20711663     DOI： 10.1007/s10549-010-1050-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  4 in total

1.  Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network.

Authors:  Katri Pylkäs; Mikko Vuorela; Meeri Otsukka; Anne Kallioniemi; Arja Jukkola-Vuorinen; Robert Winqvist
Journal:  PLoS Genet       Date:  2012-06-21       Impact factor: 5.917

2.  Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.

Authors:  Tuomo Mantere; Anna Tervasmäki; Anna Nurmi; Katrin Rapakko; Saila Kauppila; Jiangbo Tang; Johanna Schleutker; Anne Kallioniemi; Jaana M Hartikainen; Arto Mannermaa; Pentti Nieminen; Riitta Hanhisalo; Sini Lehto; Maija Suvanto; Mervi Grip; Arja Jukkola-Vuorinen; Maria Tengström; Päivi Auvinen; Anders Kvist; Åke Borg; Carl Blomqvist; Kristiina Aittomäki; Roger A Greenberg; Robert Winqvist; Heli Nevanlinna; Katri Pylkäs
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

3.  FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.

Authors:  Johanna I Kiiski; Anna Tervasmäki; Liisa M Pelttari; Sofia Khan; Tuomo Mantere; Katri Pylkäs; Arto Mannermaa; Maria Tengström; Anders Kvist; Åke Borg; Veli-Matti Kosma; Anne Kallioniemi; Johanna Schleutker; Ralf Bützow; Carl Blomqvist; Kristiina Aittomäki; Robert Winqvist; Heli Nevanlinna
Journal:  Breast Cancer Res Treat       Date:  2017-07-12       Impact factor: 4.872

4.  Evaluating the role of NTHL1 p.Q90* allele in inherited breast cancer predisposition.

Authors:  Timo Kumpula; Anna Tervasmäki; Tuomo Mantere; Susanna Koivuluoma; Laura Huilaja; Kaisa Tasanen; Robert Winqvist; Richarda M de Voer; Katri Pylkäs
Journal:  Mol Genet Genomic Med       Date:  2020-09-19       Impact factor: 2.183
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.